Table 1.
Absolute numbers of analysed target lesions by anatomic region
| Region | HL | DLBCL | FL | MCL | Total |
|---|---|---|---|---|---|
| Nodal | |||||
| Cervical | 1 | 2 | 2 | 4 | 9 |
| Infraclavicular | 4 | 2 | 0 | 0 | 6 |
| Axillary | 0 | 6 | 1 | 1 | 8 |
| Mediastinal | 14 | 4 | 2 | 2 | 22 |
| Hilar | 8 | 2 | 0 | 1 | 11 |
| Mesenteric | 2 | 8 | 2 | 3 | 15 |
| Periaortic | 1 | 8 | 4 | 4 | 17 |
| Pelvic | 0 | 8 | 13 | 8 | 29 |
| Inguinal | 0 | 5 | 8 | 4 | 17 |
| Extranodal | |||||
| Waldeyer’s ring | 0 | 1 | 0 | 0 | 1 |
| Lungs | 0 | 1 | 0 | 4 | 5 |
| Spleen | 1 | 0 | 0 | 0 | 1 |
| Stomach | 0 | 2 | 0 | 1 | 3 |
| Small intestine | 0 | 1 | 0 | 0 | 1 |
| Large intestine | 0 | 1 | 0 | 0 | 1 |
| Bones | 1 | 6 | 5 | 0 | 12 |
| Soft tissues | 0 | 2 | 0 | 0 | 2 |
| Other | 0 | 5 | 1 | 0 | 6 |
HL Hodgkin lymphoma, DLBCL diffuse large B-cell lymphoma. FL follicular lymphoma, MCL mantle cell lymphoma